FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

40632911000001108: Kerendia 10mg tablets (Bayer Plc) 28 tablet 2 x 14 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 11-May 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1912891000001113 Kerendia 10mg tablets (Bayer Plc) 28 tablet 2 x 14 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1912901000001114 Kerendia 10mg tablets (Bayer Plc) 28 tablet 2 x 14 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Kerendia 10mg tablets (Bayer Plc) 28 tablet 2 x 14 tablets Has specific active ingredient Finerenone true Inferred relationship Existential restriction modifier
Kerendia 10mg tablets (Bayer Plc) 28 tablet 2 x 14 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Kerendia 10mg tablets (Bayer Plc) 28 tablet 2 x 14 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Kerendia 10mg tablets (Bayer Plc) 28 tablet 2 x 14 tablets Has AMP Kerendia 10mg tablets (Bayer Plc) true Inferred relationship Existential restriction modifier
Kerendia 10mg tablets (Bayer Plc) 28 tablet 2 x 14 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Kerendia 10mg tablets (Bayer Plc) 28 tablet 2 x 14 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Kerendia 10mg tablets (Bayer Plc) 28 tablet 2 x 14 tablets Is a Finerenone 10mg tablets 28 tablet true Inferred relationship Existential restriction modifier
Kerendia 10mg tablets (Bayer Plc) 28 tablet 2 x 14 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Kerendia 10mg tablets (Bayer Plc) 28 tablet 2 x 14 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Kerendia 10mg tablets (Bayer Plc) 28 tablet 2 x 14 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Kerendia 10mg tablets (Bayer Plc) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Kerendia 10mg tablets (Bayer Plc) 28 tablet 2 x 14 tablets Has specific active ingredient Finerenone false Inferred relationship Existential restriction modifier
Kerendia 10mg tablets (Bayer Plc) 28 tablet 2 x 14 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
Kerendia 10mg tablets (Bayer Plc) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Kerendia 10mg tablets (Bayer Plc) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start